Investors claim Novo Nordisk misled the market about CagriSema's tolerability, after disappointing clinical trial results wiped billions off its market cap.
JPMorgan, Schwab, UBS and Stephens Inc. are among the firms that have managed Trump's fortune in accounts worth at least $858 million, a CNBC analysis found.
China was once Nike's fastest-growing region but the company has lost relevance among young consumers and ceded market share to smaller, domestic brands.